Pulmonary Surfactant Effects and Replacement in Oxygen Toxicity and Other ARDS-Type Lung Injuries

  • B. A. Holm
  • S. Matalon
  • R. H. Notter
Conference paper

Abstract

In the thirty years since the discovery of surface active material in the alveolar region of the lung, and its fundamental importance for respiration, extensive studies have been directed at characterizing and understanding the pulmonary surfactant system (e.g. [20, 24]). A basic driving force for much of this lung surfactant (LS) research was the discovery in 1959 that the respiratory distress syndrome of the premature newborn (RDS) resulted directly from a lack of surfactant-producing type II pneumocytes in the immature lung, giving rise to a primary deficiency in alveolar surfactant at birth [1]. After the fundamental importance of LS for normal respiration was established, extensive research efforts were initiated to develop beneficial exogenous surfactant replacement therapy for neonatal RDS. The pathway to such therapy has been longer than many researchers expected, but since the beginning of this decade, it has become increasingly clear that exogenous surfactant replacement in RDS is highly efficacious in premature infants [e.g. 5, 20 (for review), 27, 29.

Keywords

Placebo Permeability Surfactant Toxicity Dioxide 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Avery ME, Mead J (1959) Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child 97: 517–523Google Scholar
  2. 2.
    Bermel M, McBride JT, Notter RH (1984) Lavaged excised rat lungs as a model of surfactant-deficiency. Lung 162: 99–113PubMedCrossRefGoogle Scholar
  3. 3.
    Berry D, Ikegami M, Jobe A (1986) Respiratory distress and surfactant inhibition following vagotomy in rabbits. J Appl Physiol 61: 1741–1748PubMedGoogle Scholar
  4. 4.
    Clark JM, Lambertsen CJ (1971) Pulmonary oxygen toxicity: a review. Pharmacol Rev 23: 37–133PubMedGoogle Scholar
  5. 5.
    Egan EA, Notter RH, Kwong MS, Shapiro DL (1983) Natural and artifical lung surfactant replacement therapy in premature lambs. J Appl Physiol 55: 875–883PubMedGoogle Scholar
  6. 6.
    Enhorning G (1977) Pulsating bubble technique for evaluating pulmonary surfactant. J Appl Physiol 43: 198–203PubMedGoogle Scholar
  7. 7.
    Gross NJ, Smith DM (1981) Impaired surfactant phospholipid metabolism in hyperoxic mouse lungs. J Appl Physiol 51: 1198–1203PubMedGoogle Scholar
  8. 8.
    Holm BA, Notter RH (1987) Effects of hemoglobin and red blood cell membrane lipids on the biophysical and physiological activity of pulmonary surfactant. J Appl Physiol 63: 1434–1442PubMedGoogle Scholar
  9. 9.
    Holm BA, Notter RH, Finkelstein JN, Matalon S (1987) Changes in type II pneumocytes during injury and recovery from hyperoxia. Am Rev Respir Dis 135: 15AGoogle Scholar
  10. 10.
    Holm BA, Notter RH (1986) Pulmonary surfactant effects in sublethal hyperoxic lung injury. In: Taylor A, Matalon S, Ward P (eds) Physiology of oxygen radicals. APS, Bethesda, pp 71–86Google Scholar
  11. 11.
    Holm BA, Notter RH, Siegle JC, Matalon S (1985) Pulmonary physiological and surfactant changes during injury and recovery from hyperoxia. J Appl Physiol 59: 1402–1409PubMedGoogle Scholar
  12. 12.
    Holm BA, Notter RH, Finkelstein JN (1985) Surface property changes from interactions of albumin with natural lung surfactant and extracted lung lipids. Chem Phys Lipids 38: 287–298PubMedCrossRefGoogle Scholar
  13. 13.
    Hopewell PC, Murray J (1977) The adult respiratory distress syndrome. In: Shibel EM, Moser KM (eds) Respiratory emergencies. Mosby, St Louis, p 101Google Scholar
  14. 14.
    Jobe A, Machiko I, Jacobs H, Jones S, Conaway D (1983) Permeability of premature lamb lungs to protein and the effect of surfactant on that permeability. J Appl Physiol 55: 169–176PubMedGoogle Scholar
  15. 15.
    Kwong MC, Egan EA, Notter RH, Shapiro DL (1985) Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants. Pediatrics 76: 585–592PubMedGoogle Scholar
  16. 16.
    Matalon S, Egan EA (1981) Effects of 100% 02 breathing on permeability of alveolar epithelium to solute. J Appl Physiol 50: 859–863PubMedGoogle Scholar
  17. 17.
    Matalon S, Egan EA (1984) Interstitial fluid volumes and albumin spaces in pulmonary oxygen toxicity. J Appl Physiol 57: 1767–1772PubMedGoogle Scholar
  18. 18.
    Matalon S, Holm BA, Notter RH (1987) Mitigation of hyperoxic injury by exogenous surfactant supplementation. J Appl Physiol 62: 756–761PubMedGoogle Scholar
  19. 19.
    Nieman GF, Bredenberg CE (1985) High surface tension pulmonary edema induced by detergent aerosol. J Appl Physiol 58: 129–136PubMedGoogle Scholar
  20. 20.
    Notter RH, Shapiro DL (1987) Lung surfactants for replacement therapy: biochemical, biophysical and clinical aspects. Clin Perinatol 14: 433–479PubMedGoogle Scholar
  21. 21.
    Notter RH, Shapiro DL, Ohning B, Whitsett J (1987) Biophysical activity of synthetic phospholipids combined with purified lung surfactant 6,000 dalton apoprotein. Chem Phys Lipids 44: 1–17PubMedCrossRefGoogle Scholar
  22. 22.
    Notter RH, Penney DP, Finkelstein JN, Shapiro DL (1986) Adsorption of natural lung surfactant and phospholipid extracts related to tubular myelin formation. Pediatr Res 20: 97–101PubMedCrossRefGoogle Scholar
  23. 23.
    Notter RH, Egan EA, Kwong MS, Holm BA, Shapiro DL (1985) Lung surfactant replacement in premature lambs with extracted lipids from bovine lung lavage: effects of dose, dispersion technique, and gestational age. Pediatr Res 19: 570–577CrossRefGoogle Scholar
  24. 24.
    Notter RH, Finkelstein JN (1984) Pulmonary surfactant: an interdisciplinary approach. J Appl Physiol 57: 1613–1624PubMedGoogle Scholar
  25. 25.
    Raj JU (1985) Alveolar liquid pressure in excised air-inflated lungs of mature and immature fetal rabbits (abstr). Physiologist 28: 349Google Scholar
  26. 26.
    Rinaldo JE, Rogers RM (1982) Adult respiratory distress syndrome, changing concepts of lung injury and repair. N Engl J Med 15: 900–909CrossRefGoogle Scholar
  27. 27.
    Robertson B, van Golde LMG, Batenburg JJ (eds) (1984) Pulmonary surfactant. Elsevier, AmsterdamGoogle Scholar
  28. 28.
    Seeger W, Stohr G, Wolf HRD, Neuhof H (1985) Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J Appl Physiol 58: 326–338PubMedGoogle Scholar
  29. 29.
    Shapiro DL, Notter RH, Morin FC, Deluga K, Golub LM, Sinkin R, Weiss K, Cox C (1985) A double-blind randomized clinical trial of a calf lung surfactant extract administered at birth to very premature infants for prevention of the respiratory distress syndrome. Pediatrics 75: 593–599Google Scholar
  30. 30.
    Whitsett J, Ohning BL, Ross G, Meuth J, Weaver T, Holm BA, Shapiro DL, Notter RH (1986) Hydrophobic surfactant-associated protein in whole lung surfactant and its importance for biophysical activity in lung surfactant extracts used for replacement therapy. Pediatr Res 20: 460–467PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • B. A. Holm
  • S. Matalon
  • R. H. Notter

There are no affiliations available

Personalised recommendations